 WOBURN, Mass., April 01, 2022 GLOBE NEWSWIRE -- Biofrontera Inc. Nasdaq: BFRI, a biopharmaceutical company specializing in the commercialization of dermatological products, announced today it will report financial results for the three months and full year ended December 31, 2021 before the opening of the U.S. financial markets on Friday, April 8, 2022 and will host a conference call that same day beginning at 11:00 a.m. Eastern time to discuss those results, provide a business update and answer questions. 